Mutations of Akt are relatively rare in breast cancer, however, aberrant activation of either upstream PIK3CA or polymorphism of the PH domain and leucine rich repeat protein phosphatase 2 (PHLPP2) gene can result in Akt expression. Here, AKT1 is linked to breast carcinoma.